Eplerenone for chronic central serous chorioretinopathy in patients with active, previously untreated disease for more than 4 months (VICI): a randomised, double-blind, placebo-controlled trial
Lotery, Andrew, Sivaprasad, Sobha, O'Connell, Abby, Harris, Rosie A, Culliford, Lucy, Ellis, Lucy, Cree, Angela, Madhusudhan, Savita, Behar-Cohen, Francine, Chakravarthy, Usha, Peto, Tunde, Rogers, ChVolume:
395
Langue:
english
Journal:
The Lancet
DOI:
10.1016/S0140-6736(19)32981-2
Date:
January, 2020
Fichier:
PDF, 901 KB
english, 2020
File converter
Plus de résultats de recherche
More benefits 
